Small-molecule screening yields a compound that inhibits the cancer-associated transcription factor Hes1 via the PHB2 chaperone-Reference-Cited by-同舟云学术

Small-molecule screening yields a compound that inhibits the cancer-associated transcription factor Hes1 via the PHB2 chaperone

Published:2018-05 Issue:21 Volume:293 Page:8285-8294
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Perron Amelie,Nishikawa Yoshihiro,Iwata Jun,Shimojo Hiromi,Takaya Junichiro,Kobayashi Kumiko,Imayoshi Itaru,Mbenza Naasson M.,Takenoya Mihoko,Kageyama Ryoichiro,Kodama Yuzo,Uesugi Motonari

Funder

MEXT | Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference56 articles.

1. Dynamic expression and roles of Hes factors in neural development;Kageyama;Cell Tissue Res,2015

2. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia;Weng;Science,2004

3. Notch mediates TGF α-induced changes in epithelial differentiation during pancreatic tumorigenesis;Miyamoto;Cancer Cell,2003

4. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo;Sjölund;J. Clin. Invest,2008

5. JAGGED1 expression is associated with prostate cancer metastasis and recurrence;Santagata;Cancer Res,2004

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prohibitin 2: A key regulator of cell function;Life Sciences;2024-02

2. PHB2 promotes SHIP2 ubiquitination via the E3 ligase NEDD4 to regulate AKT signaling in gastric cancer;Journal of Experimental & Clinical Cancer Research;2024-01-11

3. PHB2 Promotes SHIP2 Ubiquitination via the E3 ligase NEDD4 to Regulate AKT Signaling in Gastric Cancer;2023-10-11

4. A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP10-N1ICD interaction to inhibit chemoresistance in Notch1-hyperactivated pancreatic cancer;Cell Discovery;2023-09-15

5. Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies;Cells;2023-07-14